Chemotherapy sensitivity and response assays: are the ASCO guidelines for clinical trial design too restrictive?
Wieand
H Samuel
HS
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm; D004354:Drug Screening Assays, Antitumor / Q000592:standards*; D017408:Guidelines as Topic; D006801:Humans; D008495:Medical Oncology / Q000592:standards; D009369:Neoplasms / Q000188:drug therapy*; D012680:Sensitivity and Specificity; D012955:Societies, Medical; D014481:United States
D000970:Antineoplastic Agents